Cited by 224Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and OutcomesNeural and Behavioral Psychology Studies

Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues

Open access
Volkow, Nora D., Wang, Gene-Jack, Telang, Frank, Fowler, Joanna S., Logan, Jean, Childress, Anna-Rose, Jayne, Millard, Ma, Yeming +1 more·2008·NeuroImage

Abstract

Imaging studies have shown an association between dopamine increases in striatum and cue induced craving in cocaine abusers. However, the extent to which dopamine increases reflect a primary rather than a secondary response to the cues remains unclear. Here we evaluated the extent to which dopamine increases by themselves can induce craving in cocaine abusers. Using PET and [(11)C]raclopride (D2 receptor radioligand sensitive to competition with endogenous dopamine) we show that in cocaine abusers (n=20) oral methylphenidate (20 mg), which significantly increased dopamine in striatum, did not induce craving unless subjects were concomitantly exposed to cocaine cues (video scenes of subjects self-administering cocaine). This suggests that dopamine increases associated with conditioned cues are not primary responses but reflect downstream stimulation of dopamine cells (presumably glutamatergic afferents from prefrontal cortex and/or amygdala). Inasmuch as afferent stimulation of dopamine neurons results in phasic cell firing these findings suggest that "fast" dopamine increases, in contrast to the "slow" dopamine increases as achieved when using oral methylphenidate (mimicking tonic dopamine cell firing), are required for cues to trigger craving. The fact that methylphenidate induced craving only when given with the cocaine cues highlights the context dependency of methylphenidate's effects and suggests that its use for the treatment of ADHD subjects with co-morbid drug abuse should not increase craving.

Integrity signals

Registry

Crossref · 10.1016/j.neuroimage.2007.09.059

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The literature supports the view that stimulant treatment for ADHD either has no impact on risk for substance abuse, or may even lower the risk of substance abuse by reducing the early onset of substance abuse in adolescents.

    “Despite concerns that pharmacotherapy with stimulant medication may be a risk factor for substance abuse, the literature supports the view that stimulant treatment for ADHD either has no impact in risk for substance abuse, or may even lower the risk of substance abuse by reducing the early onset of substance abuse in adolescents [206,254,257-259].”

The citation lists haven’t been fetched yet

References 61 · Cited by 224

Authors
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C.
Affiliations
  • National Institute on Drug Abuse (US)
  • Brookhaven National Laboratory (US)
  • National Institute on Alcohol Abuse and Alcoholism (US)
  • Philadelphia VA Medical Center (US)
Corresponding author
Volkow, Nora D.
Venue
NeuroImage
Publisher
Elsevier BV
Published
2008-02
Volume
39
Issue
3
Pages
1266-1273
ISSN
1053-8119 (ISSN-L)
OpenAlex
W2009892798
Cited by
224
References
61
Citations by year
2025: 7 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 8 · 2020: 46 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 10 · 2015: 11 · 2014: 17 · 2013: 20 · 2012: 18
FWCI
5.04
Type
journal article
Language
en
Open access
Locations
  • NeuroImage (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Drug Abuse (DA06278-15, R01DA006278)
  • National Center for Research Resources (#M01RR10710, M01RR010710)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
Keywords
cocaine craving, cocaine abusers, striatal dopamine, cocaine cues, methylphenidate, raclopride, conditioned cues, phasic dopamine release, glutamatergic afferents, prefrontal cortex, amygdala, context sensitivity, ADHD comorbidity, cocaine self-administration
MeSH terms
Adult, Blood Pressure, Brain, Brain Chemistry, Cues, Dopamine, Female, Heart Rate, Humans, Image Processing, Computer-Assisted, Male, Methylphenidate, Middle Aged, Surveys and Questionnaires, Tomography, Neostriatum, Dopamine Antagonists, Dopamine Uptake Inhibitors, Cocaine-Related Disorders, Raclopride, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review